186 related articles for article (PubMed ID: 34146516)
21. A UVB-responsive common variant at chromosome band 7p21.1 confers tanning response and melanoma risk via regulation of the aryl hydrocarbon receptor, AHR.
Xu M; Mehl L; Zhang T; Thakur R; Sowards H; Myers T; Jessop L; Chesi A; Johnson ME; Wells AD; Michael HT; Bunda P; Jones K; Higson H; Hennessey RC; Jermusyk A; Kovacs MA; Landi MT; Iles MM; Goldstein AM; ; Choi J; Chanock SJ; Grant SFA; Chari R; Merlino G; Law MH; Brown KM
Am J Hum Genet; 2021 Sep; 108(9):1611-1630. PubMed ID: 34343493
[TBL] [Abstract][Full Text] [Related]
22. Integrative analysis of liver-specific non-coding regulatory SNPs associated with the risk of coronary artery disease.
Selvarajan I; Toropainen A; Garske KM; López Rodríguez M; Ko A; Miao Z; Kaminska D; Õunap K; Örd T; Ravindran A; Liu OH; Moreau PR; Jawahar Deen A; Männistö V; Pan C; Levonen AL; Lusis AJ; Heikkinen S; Romanoski CE; Pihlajamäki J; Pajukanta P; Kaikkonen MU
Am J Hum Genet; 2021 Mar; 108(3):411-430. PubMed ID: 33626337
[TBL] [Abstract][Full Text] [Related]
23. Identification of an enhancer region within the TP63/LEPREL1 locus containing genetic variants associated with bladder cancer risk.
Dudek AM; Vermeulen SH; Kolev D; Grotenhuis AJ; Kiemeney LALM; Verhaegh GW
Cell Oncol (Dordr); 2018 Oct; 41(5):555-568. PubMed ID: 29956121
[TBL] [Abstract][Full Text] [Related]
24. Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.
Fletcher O; Johnson N; Orr N; Hosking FJ; Gibson LJ; Walker K; Zelenika D; Gut I; Heath S; Palles C; Coupland B; Broderick P; Schoemaker M; Jones M; Williamson J; Chilcott-Burns S; Tomczyk K; Simpson G; Jacobs KB; Chanock SJ; Hunter DJ; Tomlinson IP; Swerdlow A; Ashworth A; Ross G; dos Santos Silva I; Lathrop M; Houlston RS; Peto J
J Natl Cancer Inst; 2011 Mar; 103(5):425-35. PubMed ID: 21263130
[TBL] [Abstract][Full Text] [Related]
25. Chromatin Accessibility of Human Mitral Valves and Functional Assessment of MVP Risk Loci.
Kyryachenko S; Georges A; Yu M; Barrandou T; Guo L; Bruneval P; Rubio T; Gronwald J; Baraki H; Kutschka I; Aras KK; Efimov IR; Norris RA; Voigt N; Bouatia-Naji N
Circ Res; 2021 Mar; 128(5):e84-e101. PubMed ID: 33508947
[TBL] [Abstract][Full Text] [Related]
26. Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression.
Darabi H; McCue K; Beesley J; Michailidou K; Nord S; Kar S; Humphreys K; Thompson D; Ghoussaini M; Bolla MK; Dennis J; Wang Q; Canisius S; Scott CG; Apicella C; Hopper JL; Southey MC; Stone J; Broeks A; Schmidt MK; Scott RJ; Lophatananon A; Muir K; Beckmann MW; Ekici AB; Fasching PA; Heusinger K; Dos-Santos-Silva I; Peto J; Tomlinson I; Sawyer EJ; Burwinkel B; Marme F; Guénel P; Truong T; Bojesen SE; Flyger H; Benitez J; González-Neira A; Anton-Culver H; Neuhausen SL; Arndt V; Brenner H; Engel C; Meindl A; Schmutzler RK; ; Arnold N; Brauch H; Hamann U; Chang-Claude J; Khan S; Nevanlinna H; Ito H; Matsuo K; Bogdanova NV; Dörk T; Lindblom A; Margolin S; ; Kosma VM; Mannermaa A; Tseng CC; Wu AH; Floris G; Lambrechts D; Rudolph A; Peterlongo P; Radice P; Couch FJ; Vachon C; Giles GG; McLean C; Milne RL; Dugué PA; Haiman CA; Maskarinec G; Woolcott C; Henderson BE; Goldberg MS; Simard J; Teo SH; Mariapun S; Helland Å; Haakensen V; Zheng W; Beeghly-Fadiel A; Tamimi R; Jukkola-Vuorinen A; Winqvist R; Andrulis IL; Knight JA; Devilee P; Tollenaar RA; Figueroa J; García-Closas M; Czene K; Hooning MJ; Tilanus-Linthorst M; Li J; Gao YT; Shu XO; Cox A; Cross SS; Luben R; Khaw KT; Choi JY; Kang D; Hartman M; Lim WY; Kabisch M; Torres D; Jakubowska A; Lubinski J; McKay J; Sangrajrang S; Toland AE; Yannoukakos D; Shen CY; Yu JC; Ziogas A; Schoemaker MJ; Swerdlow A; Borresen-Dale AL; Kristensen V; French JD; Edwards SL; Dunning AM; Easton DF; Hall P; Chenevix-Trench G
Am J Hum Genet; 2015 Jul; 97(1):22-34. PubMed ID: 26073781
[TBL] [Abstract][Full Text] [Related]
27. The subcellular localization of IGFBP5 affects its cell growth and migration functions in breast cancer.
Akkiprik M; Hu L; Sahin A; Hao X; Zhang W
BMC Cancer; 2009 Apr; 9():103. PubMed ID: 19341485
[TBL] [Abstract][Full Text] [Related]
28. Somatic mutation and functional polymorphism of a novel regulatory element in the HGF gene promoter causes its aberrant expression in human breast cancer.
Ma J; DeFrances MC; Zou C; Johnson C; Ferrell R; Zarnegar R
J Clin Invest; 2009 Mar; 119(3):478-91. PubMed ID: 19188684
[TBL] [Abstract][Full Text] [Related]
29. Decreased expression of insulin-like growth factor binding protein-5 during N-(4-hydroxyphenyl)retinamide-induced neuronal differentiation of ARPE-19 human retinal pigment epithelial cells: regulation by CCAAT/enhancer-binding protein.
Samuel W; Kutty RK; Vijayasarathy C; Pascual I; Duncan T; Redmond TM
J Cell Physiol; 2010 Sep; 224(3):827-36. PubMed ID: 20583135
[TBL] [Abstract][Full Text] [Related]
30. Genetic variants at chromosomes 2q35, 5p12, 6q25.1, 10q26.13, and 16q12.1 influence the risk of breast cancer in men.
Orr N; Cooke R; Jones M; Fletcher O; Dudbridge F; Chilcott-Burns S; Tomczyk K; Broderick P; Houlston R; Ashworth A; Swerdlow A
PLoS Genet; 2011 Sep; 7(9):e1002290. PubMed ID: 21949660
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive functional annotation of 77 prostate cancer risk loci.
Hazelett DJ; Rhie SK; Gaddis M; Yan C; Lakeland DL; Coetzee SG; ; ; Henderson BE; Noushmehr H; Cozen W; Kote-Jarai Z; Eeles RA; Easton DF; Haiman CA; Lu W; Farnham PJ; Coetzee GA
PLoS Genet; 2014 Jan; 10(1):e1004102. PubMed ID: 24497837
[TBL] [Abstract][Full Text] [Related]
32. Cooperation between the human estrogen receptor (ER) and MCF-7 cell-specific transcription factors elicits high activity of an estrogen-inducible enhancer from the trout ER gene promoter.
Lazennec G; Kern L; Salbert G; Saligaut D; Valotaire Y
Mol Endocrinol; 1996 Sep; 10(9):1116-26. PubMed ID: 8885246
[TBL] [Abstract][Full Text] [Related]
33. Functional variants at the 21q22.3 locus involved in breast cancer progression identified by screening of genome-wide estrogen response elements.
Hsiung CN; Chu HW; Huang YL; Chou WC; Hu LY; Hsu HM; Wu PE; Hou MF; Yu JC; Shen CY
Breast Cancer Res; 2014 Oct; 16(5):455. PubMed ID: 25298020
[TBL] [Abstract][Full Text] [Related]
34. Re-expression of SPR1 in breast cancer cells by phorbol 12-myristate 13-acetate (PMA) or UV irradiation is mediated by the AP-1 binding site in the SPR1 promoter.
Anisowicz A; Sotiropoulou G; Sager R
Mol Med; 1999 Aug; 5(8):526-41. PubMed ID: 10501656
[TBL] [Abstract][Full Text] [Related]
35. Assessing interactions between common genetic variant on 2q35 and hormone receptor status with breast cancer risk: evidence based on 26 studies.
Huang T; Hong J; Lin W; Yang Q; Ni K; Wu Q; Sun J
PLoS One; 2013; 8(8):e69056. PubMed ID: 23976942
[TBL] [Abstract][Full Text] [Related]
36. KDM6B Counteracts EZH2-Mediated Suppression of
Wang W; Lim KG; Feng M; Bao Y; Lee PL; Cai Y; Chen Y; Zhang H; Marzese D; Hoon DSB; Yu Q
Mol Cancer Ther; 2018 Sep; 17(9):1973-1983. PubMed ID: 29925528
[TBL] [Abstract][Full Text] [Related]
37. Systematic Functional Interrogation of Genes in GWAS Loci Identified ATF1 as a Key Driver in Colorectal Cancer Modulated by a Promoter-Enhancer Interaction.
Tian J; Chang J; Gong J; Lou J; Fu M; Li J; Ke J; Zhu Y; Gong Y; Yang Y; Zou D; Peng X; Yang N; Mei S; Wang X; Zhong R; Cai K; Miao X
Am J Hum Genet; 2019 Jul; 105(1):29-47. PubMed ID: 31204011
[TBL] [Abstract][Full Text] [Related]
38. Candidate Causal Variants at the 8p12 Breast Cancer Risk Locus Regulate
Glubb DM; Shi W; Beesley J; Fachal L; Pritchard JL; McCue K; Barnes DR; Antoniou AC; Dunning AM; Easton DF; Chenevix-Trench G
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31936698
[TBL] [Abstract][Full Text] [Related]
39. Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk.
Painter JN; O'Mara TA; Batra J; Cheng T; Lose FA; Dennis J; Michailidou K; Tyrer JP; Ahmed S; Ferguson K; Healey CS; Kaufmann S; Hillman KM; Walpole C; Moya L; Pollock P; Jones A; Howarth K; Martin L; Gorman M; Hodgson S; ; ; De Polanco MM; Sans M; Carracedo A; Castellvi-Bel S; Rojas-Martinez A; Santos E; Teixeira MR; Carvajal-Carmona L; Shu XO; Long J; Zheng W; Xiang YB; ; Montgomery GW; Webb PM; Scott RJ; McEvoy M; Attia J; Holliday E; Martin NG; Nyholt DR; Henders AK; Fasching PA; Hein A; Beckmann MW; Renner SP; Dörk T; Hillemanns P; Dürst M; Runnebaum I; Lambrechts D; Coenegrachts L; Schrauwen S; Amant F; Winterhoff B; Dowdy SC; Goode EL; Teoman A; Salvesen HB; Trovik J; Njolstad TS; Werner HM; Ashton K; Proietto T; Otton G; Tzortzatos G; Mints M; Tham E; ; Hall P; Czene K; Liu J; Li J; Hopper JL; Southey MC; ; Ekici AB; Ruebner M; Johnson N; Peto J; Burwinkel B; Marme F; Brenner H; Dieffenbach AK; Meindl A; Brauch H; ; Lindblom A; Depreeuw J; Moisse M; Chang-Claude J; Rudolph A; Couch FJ; Olson JE; Giles GG; Bruinsma F; Cunningham JM; Fridley BL; Børresen-Dale AL; Kristensen VN; Cox A; Swerdlow AJ; Orr N; Bolla MK; Wang Q; Weber RP; Chen Z; Shah M; French JD; Pharoah PD; Dunning AM; Tomlinson I; Easton DF; Edwards SL; Thompson DJ; Spurdle AB
Hum Mol Genet; 2015 Mar; 24(5):1478-92. PubMed ID: 25378557
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of functional genetic variants at 6q25.1 and risk of breast cancer in a Chinese population.
Wang Y; He Y; Qin Z; Jiang Y; Jin G; Ma H; Dai J; Chen J; Hu Z; Guan X; Shen H
Breast Cancer Res; 2014 Aug; 16(4):422. PubMed ID: 25116933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
